Skip to content

Concord Biotech IPO opens tomorrow: 10 things to know before bid for the issue

Concord Biotech IPO | The issue comprises only an offer for sale (OFS) by Helix Investment Holdings Pte Limited, which is backed by Quadria Capital Fund LP, a healthcare-focused private equity fund in Asia.

Read More

​ Concord Biotech IPO | The issue comprises only an offer for sale (OFS) by Helix Investment Holdings Pte Limited, which is backed by Quadria Capital Fund LP, a healthcare-focused private equity fund in Asia. Concord Biotech IPO | The issue comprises only an offer for sale (OFS) by Helix Investment Holdings Pte Limited, which is backed by Quadria Capital Fund LP, a healthcare-focused private equity fund in Asia.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish